Skip to content

Feverfew

A migraine herb sold on a marker molecule that may not be the active one.

  • CategoryCognitive & Mood
  • FormTanacetum parthenium leaf, parthenolide-standardized
  • EvidenceClinical trials on file

Where to get Feverfew

iHerb
Tanacetum parthenium leaf, parthenolide-standardized

Cam’s partner link opens iHerb on this product. No code needed; the link credits Cam.

Shop on iHerb

The short version

  • What it doesParthenolide is a Michael acceptor, and that single chemical fact explains both its pharmacology and its side effects. It is a germacranolide sesquiterpene lactone carrying an alpha-methylene-gamma-lactone, an electron-poor alkene that reacts covalently with nucleophilic thiols.
  • Who it is forPeople with frequent migraine looking at herbal prophylaxis, who will note down attack frequency before starting.
  • What to watchA case report documents altered coagulation test results and vaginal bleeding attributed to feverfew. Additive risk with anticoagulants and antiplatelets, and a reason to stop well before surgery.

How Feverfew works

Parthenolide, the sesquiterpene lactone the labels standardize to, carries an alpha-methylene-gamma-lactone that acts as a Michael acceptor: it alkylates cysteine residues, including Cys179 of IKK-beta, which blocks NF-kappa-B activation, and it also agonizes TRPA1 on sensory neurons, where prolonged activation defunctionalizes the terminal. Both are real chemistry.

Read the rest of how it works

What the standardization does not capture is that feverfew leaf contains a large family of other sesquiterpene lactones and flavonoids whose proportions vary with chemotype, plant part and growing region, and that the extract with the best controlled result is a supercritical carbon dioxide preparation with a profile unlike an alcoholic extract of the same parthenolide content. The marker molecule and the active principle may not be the same thing, which is an uncomfortable position for a category that sells itself on a percentage.

Feverfew: serving, timing and spacing

Suggested serving
Dried leaf products run 100–380 mg daily; extracts state a parthenolide percentage, commonly 0.2–0.7%. Prophylaxis is judged over months, not days.
How often
Daily, as prophylaxis rather than for an attack in progress
When
With food, at the same time each day. This is a prophylactic: it does nothing for a headache that has already started, and taking it reactively is the commonest way people conclude it does not work
Spacing that matters for safety
Taper rather than stop - abrupt discontinuation after long-term use has a described rebound of headache, anxiety and joint stiffness - and stop it two weeks before surgery on the coagulation grounds

General referenceA general reference intake for education, not a prescription. The label on the product you buy is the final word.

Good to know

Buy by extract type, not by parthenolide percentage. The percentage tells you what one molecule is doing in the bottle, and the trial that worked best was not run on that molecule alone.

Research on Feverfew5 evidence notes: clinical, correlative, theoretical

Each note sits under the kind of evidence it stands on. A thin or missing trial means nobody has run it yet, not that it doesn’t work. How the evidence tiers work

Human clinical evidence

  • Reviews of nutraceutical migraine prophylaxis place feverfew in the tier where some extracts have positive controlled data and others do not, with the extract type rather than the dose explaining much of the disagreement.

  • Chemical authentication work on commercial herbal products finds identity and content problems across the botanical supplement market, which is the practical reason two feverfew bottles can behave differently.

  • Phytochemical characterization of Tanacetum species shows parthenolide is one member of a large sesquiterpene lactone and flavonoid profile that varies with plant part, chemotype and growing region.

Correlative data

  • Several centuries of European traditional use for fever and headache is what put this plant in the aisle. Traditional use establishes that people took it, not that it worked.

Theoretical / extrapolated benefits

  • Parthenolide alkylates cysteine residues on IKK-beta and inhibits NF-kappa-B, and separately activates TRPA1 on sensory neurons. Both are real biochemistry in a dish; neither has been shown to be the step that reduces a migraine day in a person.

Sources read for this page

  • Alenzi KA. Alteration of Coagulation Test Results and Vaginal Bleeding Associated With the Use of Feverfew (Tanacetum parthenium). J Med Cases 2021 · PMID 34434419
  • Klučevšek T. Allergic Potential of Medicinal Plants From the Asteraceae Family. Health Sci Rep 2025 · PMID 39995792
  • Ichim MC. Chemical Authentication of Botanical Ingredients: A Review of Commercial Herbal Products. Front Pharmacol 2021 · PMID 33935790
  • Kaur K. The Efficacy of Herbal Supplements and Nutraceuticals for Prevention of Migraine: Can They Help?. Cureus 2021 · PMID 33972917
  • Jahromi B. Herbal Medicine for Pain Management: Efficacy and Drug Interactions. Pharmaceutics 2021 · PMID 33670393
  • Giuliani C. An Integrative Approach to Selected Species of Tanacetum L. (Asteraceae): Insights into Morphology and Phytochemistry. Plants (Basel) 2024 · PMID 38256709

Feverfew, the deep readThe mechanism, cell to human, which form, how you would know

What Feverfew actually does

Parthenolide is a Michael acceptor, and that single chemical fact explains both its pharmacology and its side effects. It is a germacranolide sesquiterpene lactone carrying an alpha-methylene-gamma-lactone, an electron-poor alkene that reacts covalently with nucleophilic thiols. In cells the target that matters is Cys179 of IKK-beta: alkylating it blocks phosphorylation of I-kappa-B, so NF-kappa-B is never released to the nucleus and the inflammatory transcriptional program does not start.

The same reactivity gives it a second target on the neurons that matter for headache. Parthenolide activates TRPA1 on trigeminal sensory terminals, and prolonged activation defunctionalizes the terminal, reducing subsequent CGRP release — an agonist that works by exhausting the channel rather than blocking it Kaur 2021. It is the same logic as topical capsaicin, and it predicts an initial irritant phase, which is precisely what chewing the leaf produces.

And the same reactivity is why it alkylates the mucosa of anybody who chews the raw leaf. Mouth ulceration and tongue swelling are not an allergy in most cases; they are a Michael acceptor meeting the thiols in oral epithelium.

Here is the uncomfortable part, and it belongs in the mechanism section rather than buried. Feverfew leaf contains a large family of sesquiterpene lactones and flavonoids whose proportions vary with chemotype, plant part and growing region Giuliani 2024, and the extract with the best controlled migraine result is a supercritical carbon dioxide preparation whose profile is not that of an alcoholic extract of matched parthenolide content. A controlled trial of an alcoholic extract standardized to parthenolide did not beat placebo. The marker molecule and the active principle may not be the same thing.

That is a structural problem for a category whose entire quality claim is a percentage. Standardizing to parthenolide guarantees consistency of one constituent and says nothing about the rest of the profile, which is where the difference between the extracts that worked and the ones that did not appears to live.

Cell, rodent, human — and where it stops

In the plant. Phytochemical characterization of Tanacetum species shows parthenolide as one member of a broad sesquiterpene lactone and flavonoid profile that shifts with species, plant part and region Giuliani 2024. That is the analytical basis for saying two feverfew products are not the same material.

In commerce, which is a step most botanicals skip and this one cannot. A review of chemical authentication of commercial herbal products documents identity and content failures across the botanical supplement market Ichim 2021. For a plant whose active principle is uncertain and whose marker varies with chemotype, that is not a background concern — it is the main source of variance between two bottles.

In people, the reviews are split along extract lines. Nutraceutical migraine prophylaxis reviews place feverfew in the tier where some preparations have positive controlled data and others do not, with extract type rather than dose explaining much of the disagreement Kaur 2021. Reviews of herbal pain management reach the same conclusion and add the interaction profile Jahromi 2021.

The specific obstacle to transfer, stated once. A reader buying a 380 mg dried-leaf capsule is not buying the material that produced the positive trials, and no label gives them a way to tell. The percentage on the front is a measurement of the one molecule whose primacy is in doubt.

Feverfew — which form, and does it matter

Buy by extract type, not by parthenolide percentage. That is the whole form argument and it inverts what the category teaches.

Three preparations are sold. Dried leaf, 100 to 380 mg daily, which is the traditional material and the one with the weakest trial record. Alcoholic extracts standardized to a parthenolide percentage, usually 0.2 to 0.7 percent. And supercritical carbon dioxide extracts, which carry a different constituent profile because CO2 extracts lipophilic compounds and leaves polar ones behind — the same separation principle that makes CO2 extraction useful for butterbur.

Parthenolide is also chemically unstable in storage. It degrades with heat, light and time, so a bottle's stated percentage is a manufacturing figure rather than a shelf figure, and authentication work finds exactly this class of discrepancy across commercial herbal products Ichim 2021.

Exposure arithmetic, and it is small. A 380 mg leaf capsule at 0.2 percent parthenolide delivers 0.76 mg. At 0.7 percent it delivers 2.7 mg. That is a three-and-a-half-fold range across products that look identical on a shelf, and it sits underneath a plasma half-life short enough that daily dosing is about maintaining a transcriptional effect rather than a concentration.

Timescale is set by the indication. This is prophylaxis. The endpoint is migraine days per month and it is judged over three to four months Kaur 2021, which means the baseline has to be written down before the first capsule or there is nothing to compare against.

What would have to be true, and how you would know it was not

The efficacy prediction is a headache diary with a real baseline. Migraine days per month for 4 weeks before starting, then monthly for 12 weeks. Migraine frequency regresses to the mean powerfully, and people start prophylaxis after a bad month, so a baseline collected retrospectively will always flatter the supplement.

The prediction that tests the mechanism. If the TRPA1 defunctionalization account is right, there should be an early phase of increased rather than decreased sensory irritation — the capsaicin pattern — before any prophylactic benefit appears Kaur 2021. A product that produces nothing at all in week one and a large effect in week two fits the transcriptional account better than the channel one.

The safety prediction, and it is a laboratory one. A case report documents altered coagulation test results with feverfew Alenzi 2021. In anyone on an anticoagulant, INR should be checked within two weeks of starting and again after stopping — this is a herb whose most concrete published adverse effect is a number on a clotting screen, and checking it is cheap.

The prediction that cuts against the category. If parthenolide were the active principle, then two products matched on parthenolide content should perform identically. The trial record suggests they do not Kaur 2021, and anyone who finds a dried-leaf product and a CO2 extract equivalent at matched parthenolide has falsified this page's central claim.

What nobody has tested yet

Nobody knows what the active principle is. That is a remarkable thing to be able to say about a herb in continuous commercial use, and it is the honest state of the field: parthenolide is the marker, the alcoholic extract standardized to it failed, and the constituent profile that differs between the extracts that worked and those that did not has never been characterized well enough to name a replacement Giuliani 2024.

No trial has compared preparations head to head. Dried leaf against alcoholic extract against CO2 extract, matched on parthenolide, with migraine days as the endpoint, would answer the question the whole category is built on. It has not been run.

The post-feverfew syndrome has never been characterized prospectively. Rebound headache, anxiety and joint stiffness after abrupt discontinuation of long-term use is described in the clinical literature and in review Jahromi 2021, but its incidence, time course and dose-dependence are unmeasured, so nobody can say how slowly to taper.

Feverfew — its own safety story, not its category's

Feverfew's own risks are not the generic herb risks, and two of them are unusual.

Coagulation. A case report documents altered coagulation test results and vaginal bleeding attributed to feverfew Alenzi 2021. Treat it as additive with anticoagulants, antiplatelets and aspirin, and stop it well before surgery or dental extraction — surgeons ask about prescription blood thinners and rarely about herbs.

Abrupt discontinuation after long-term use. A rebound syndrome of returning headache, anxiety, and muscle and joint stiffness is described Jahromi 2021. The practical implication is to taper rather than stop, which is not something most supplements require.

Oral ulceration from chewing the leaf is the classic adverse effect, is dose-related, and follows directly from parthenolide's reactivity with tissue thiols.

Asteraceae allergy is well characterized for this family and matters more here than for most herbs. Cross-reactivity with ragweed, chrysanthemum, daisy and arnica ranges from contact dermatitis to systemic reactions Klučevšek 2025, and sesquiterpene lactones are the specific sensitizers.

Avoid in pregnancy — emmenagogue and abortifacient effects are described in traditional use — and note that identity and content failures are common enough across commercial herbal products Ichim 2021 that a product's stated species is itself part of the risk.

Feverfew safety basics5 points of its own

Its own safety story

  • A case report documents altered coagulation test results and vaginal bleeding attributed to feverfew. Additive risk with anticoagulants and antiplatelets, and a reason to stop well before surgery.
  • Abrupt discontinuation after long-term use has been described as a rebound syndrome — returning headache, anxiety, muscle and joint stiffness. Taper rather than stop.
  • Chewing the raw leaf causes mouth ulceration and tongue swelling. This is the classic adverse effect and it is dose-related.
  • Asteraceae family: cross-reactive allergy with ragweed, daisy, chrysanthemum and arnica is well described, up to contact dermatitis and systemic reactions.
  • Avoid in pregnancy — traditional use includes emmenagogue and abortifacient effects.

Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor. Pharmacists are underused and free.

Bloodwork to run5 tests in one order, code CAMERON

The effect itself has no blood test. That is a fact about the effect, and it changes how you should judge it.

  • What to watchMigraine days per month, counted on a calendar. Not severity, not an impression — days, because that is the endpoint every prophylaxis trial in this literature uses and the only one that survives a bad week.
  • How long before it means anythingTwelve weeks, with four weeks of baseline recorded BEFORE the first capsule. Prophylaxis is judged across months; and a baseline reconstructed from memory after starting will always flatter the supplement.
  • What will fool youRegression to the mean, which on this condition is stronger than on almost any other. People start prophylaxis after a bad month, and the month after a bad month is better on average whatever they take. The second confound is the extract: two bottles at the same parthenolide percentage can be different material, so a null result may be a product result rather than a molecule result.

The labs mapped to Feverfew

5 tests in one order
Marek Diagnostics · no doctor’s visit
Code CAMERON
Order these 5 tests

Code CAMERON applies automatically at checkout. Draw before you start, not after: a result with nothing to compare it to answers nothing.

The Brain Fog & Cognition panel, explained

Feverfew FAQ5 common questions

What is Feverfew?
A migraine herb sold on a marker molecule that may not be the active one. Labels standardize to parthenolide, a sesquiterpene lactone; a controlled trial of an alcoholic extract standardized to parthenolide failed, while the extract with the best trial result is a supercritical CO2 preparation with a different constituent profile. That is an awkward fact for a category whose entire quality claim is the parthenolide number.
What is the suggested dose of Feverfew?
Dried leaf products run 100–380 mg daily; extracts state a parthenolide percentage, commonly 0.2–0.7%. Prophylaxis is judged over months, not days. This is a general reference for education only. Statements have not been evaluated by the FDA and this is not medical advice.
Who is Feverfew for?
People with frequent migraine looking at herbal prophylaxis, who will note down attack frequency before starting.
Which labs show whether Feverfew is doing anything?
TSH (Thyroid-Stimulating Hormone), Vitamin B12, Methylmalonic Acid (MMA), Ferritin, Vitamin D (25-Hydroxy). Draw a baseline before you start, then recheck.
Where can I buy Feverfew?
Coach Cam sources Feverfew from vetted, top-rated brands on iHerb. Use the buy link on this page.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

The full stack plan is inside Skool

This page covers what Feverfew is, what the research says and how people take it. Skool puts it in order alongside everything else you run, peptides included.

Free on this page

What Feverfew is and how it works · The serving, its basis, and its safety lines · The research and the bloodwork that shows it

  • What Feverfew is and how it works
  • The serving, its basis, and its safety lines
  • The research and the bloodwork that shows it

Members get

  • Feverfew in your full stack: what it runs with, and what it cancels out
  • How it fits with your peptides: what it pairs with, and what it overlaps
  • The retest plan: TSH (Thyroid-Stimulating Hormone) baseline, the recheck, what a change means
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational reference only. Not medical advice. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure or prevent any disease. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy on iHerbJoin Skool